Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 38635

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSAdenosine-5'-O-(3-thiotriphosphate) (ATPγS) is an agonist of the purinergic P2Y11 receptor.1 It induces inositol phosphate accumulation in CHO-K1 cells expressing the human or canine P2Y11 receptor (EC50s = 1.2 and 19.3 µM, respectively). ATPγS (10 µM) inhibits Junin virus-induced increases in mRNA encoding bone morphogenetic protein 6 (BMP6) and reduces particle forming units (PFUs) in Junin virus-infected primary rat osteoblasts.2 It induces insulin secretion by MIN6 pancreatic β-cells when used at a concentration of 25 µM.3
WARNING This product is not for human or veterinary use.
1. An arginine/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors. Mol. Pharmacol. 60(6), 1375-1382 (2001).
2. Infection of rat osteoblasts with junin virus promotes the expression of bone morphogenetic protein 6, an osteogenic differentiation inducer. Intervirology 62(1), 1-8 (2019).
3. ATP is an essential autocrine factor for pancreatic β-